Metabolic bariatric surgery (MBS) utilization decreased by 34% from 2022 to 2025, while prescriptions for glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) increased by 140% over the same period, according to a research letter published in JAMA Surgery
GLP-1 receptor agonists address this directly, and Retatrutides triple mechanism makes that correction more powerful than any predecessor
18(5):10431053.e4
Saha, S., Sur, A., Saha, L., & Alam, M
Each batch is handled with professional care, packaged securely, and distributed with discretion to support laboratory compliance and controlled research environments
The condition reduces the amount of blood that reaches leg muscles, making even a short trip to the mailbox painful and challenging